Chronic Non-malignant Pain Clinical Trial
— PPACT-UH2Official title:
Collaborative Care for Chronic Pain in Primary Care
Verified date | December 2015 |
Source | Kaiser Permanente |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Institutional Review Board |
Study type | Interventional |
The overall aim of this study is to adopt an integrative rehabilitation approach for helping patients adopt self-management skills for managing chronic pain, limiting use of opioid medications, and identifying exacerbating factors amenable to treatment (e.g., depression, sleep problems) that is feasible and sustainable within the primary care setting.
Status | Completed |
Enrollment | 20 |
Est. completion date | June 2014 |
Est. primary completion date | June 2014 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Paneled to a primary care provider practicing at one of the primary care clinics participating in the study - =18 years of age at time of inclusion. Current adult KP member (18 years or older) - Within the last 180 days either: - 90 day supply of short acting opioid spanning at least 120 days - or more long acting opioid dispenses - Pain diagnostic ICD-9 code within the past 180 days - Diagnostic categories include but are not limited to: Back pain, neck pain, fibromyalgia, arthritis, myofascial pain, neuropathies, migraine, tension headache, temporomandibular joint disorder, carpal tunnel syndrome, nonspecific chronic pain, abdominal pain, pelvic pain |
Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Health Services Research
Country | Name | City | State |
---|---|---|---|
United States | Kaiser Permanente Center for Health Research | Portland | Oregon |
Lead Sponsor | Collaborator |
---|---|
Kaiser Permanente | Duke University, Oregon Health and Science University |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Morphine equivalents | Opioid dose measured in morphine equivalents | Collected every 3 months for 1 year | No |
Other | Patient satisfaction | Patient satisfaction with health care services | Collected every 3 months for 1 year | No |
Primary | Brief Pain Inventory | Reliable and valid tool that measures patients' pain intensity and functional interference. | Collected every 3 months for 1 year | No |
Secondary | Health care utilization and cost | Primary care and specialty care services | Collected every 3 months for 1 year | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00312195 -
Safety and Efficacy of Buprenorphine Transdermal System (BTDS) in Subjects With Chronic Nonmalignant Pain
|
Phase 3 | |
Terminated |
NCT00365898 -
Efficacy and Safety of Hydromorphone Hydrochloride Extended-Release Compared to Placebo in Subjects With Persistent Pain
|
Phase 3 | |
Completed |
NCT03761277 -
Embrace TDD: Post-Market Study to Evaluate Intrathecal Morphine as an Alternative to Systemic Opioids for Chronic Pain
|
Phase 4 | |
Completed |
NCT02113592 -
Pain Program for Active Coping & Training
|
N/A |